To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Global Health for fiscal year 2024.

Bill 118 hr 1971, also known as the "Limitation on Availability of Funds for Department of Health and Human Services, Centers for Disease Control and Prevention Global Health for Fiscal Year 2024," aims to restrict the amount of funds available for the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) Global Health program for the fiscal year 2024.

The bill seeks to impose a limitation on the funds that can be allocated to the CDC Global Health program, which is responsible for addressing global health issues and promoting public health initiatives around the world. By placing a cap on the funding for this program, the bill aims to ensure that taxpayer dollars are being used efficiently and effectively in addressing domestic health concerns.

Supporters of the bill argue that it is necessary to prioritize funding for domestic health programs and initiatives, especially in light of the ongoing COVID-19 pandemic and other public health challenges facing the United States. They believe that limiting funds for global health programs will allow for greater focus and resources to be directed towards addressing domestic health issues. Opponents of the bill, however, argue that cutting funding for global health programs could have negative consequences for global health security and could hinder efforts to prevent the spread of infectious diseases and other health threats around the world. They believe that investing in global health initiatives is crucial for protecting public health both domestically and internationally. Overall, Bill 118 hr 1971 represents a contentious issue in Congress, with supporters and opponents offering differing perspectives on the potential impact of limiting funds for the CDC Global Health program in fiscal year 2024. The outcome of this bill will have significant implications for public health funding and priorities in the United States.